BridgeBio Pharma
BBIO
#1405
Rank
C$21.23 B
Marketcap
C$109.02
Share price
-2.75%
Change (1 day)
13.51%
Change (1 year)

EPS for BridgeBio Pharma (BBIO)

EPS in 2026 (TTM): C-$4.24

According to BridgeBio Pharma 's latest financial reports the company's current EPS (TTM) is C-$4.36. In 2025 the company made an earnings per share (EPS) of C-$5.42 a decrease over its 2024 EPS that were of C-$4.09.

EPS history for BridgeBio Pharma from 2019 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$4.24-21.71%
2025C-$5.4232.63%
2024C-$4.09-27.66%
2023C-$5.6520.49%
2022C-$4.69-16.37%
2021C-$5.612.89%
2020C-$5.4561.71%
2019C-$3.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
C-$0.27-93.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
C-$1.36-68.75%๐Ÿ‡บ๐Ÿ‡ธ USA